Suppr超能文献

KRN2391、尼可地尔和地尔硫䓬对麻醉大鼠体内内皮素-1引起的心电图变化的影响。

Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.

作者信息

Harada K, Miwa A, Kaneta S, Izawa T, Fukushima H, Ogawa N

机构信息

Pharmaceutical Research Laboratory, Kirin Brewery Co. Ltd., Gunma, Japan.

出版信息

Br J Pharmacol. 1993 Jul;109(3):679-84. doi: 10.1111/j.1476-5381.1993.tb13627.x.

Abstract
  1. The effect of KRN2391, a novel vasodilator, on the changes of electrocardiogram caused by endothelin-1 (ET-1) was studied in anaesthetized rats and compared with the effects of nicorandil and diltiazem. In addition, the effect of KRN2391 on the action potential of guinea-pig papillary muscle was studied. 2. The intracoronary administration (i.c.) of ET-1 (5 micrograms) induced not only ST segment elevation of the electrocardiogram due to contraction of the coronary artery, but also arrhythmias involving atrioventricular block (A-V block), ventricular premature contraction (VPC) and ventricular fibrillation (VF), and resulted in death in most animals. However, the administration of methacholine (3 micrograms, i.c.) produced ST segment elevation alone without developing arrhythmias. 3. Pretreatment with intravenous administration of KRN2391 (30 micrograms kg-1) inhibited the ST segment elevation and the development of arrhythmias induced by ET-1, and decreased the incidence of death. 4. Nicorandil (1000 micrograms kg-1) prevented the ST segment elevation without suppression of the occurrence of VF. Diltiazem (100 micrograms kg-1) suppressed both the ST segment elevation and the occurrence of VF but not other arrhythmias. Nicorandil at 3000 micrograms kg-1 and diltiazem at 300 micrograms kg-1 produced not only a suppression of ST segment elevation and VF incidence but also a decrease in the occurrence of arrhythmias. These doses of nicorandil and diltiazem produced a decrease in death in a dose-dependent manner. 5. KRN2391 (10 and 30 micrograms kg-1), nicorandil (1000 and 3000 micrograms kg-1) and diltiazem (100 and 300 micrograms kg-1) significantly decreased mean blood pressure in a dose-dependent manner. Heart rate was decreased by nicorandil (3000 microg kg-1) and diltiazem (100 and 300 microg kg-1) but was not affected byKRN2391 (10 and 30 microg kg-1).6. KRN2391 (30 microM) significantly shortened the action potential duration of guinea-pig ventricle at 50% and 90% repolarization (APD50 and APD90). The effect of KRN2391 was inhibited by a K+channel blocker, glibenclamide (30 microM).7. These results suggest that the occurrence of ST segment elevation and arrhythmias induced by ET-1 are due to a dual direct action on both coronary vascular smooth muscle and myocardium. Therefore,the protective effects of KRN2391, nicorandil and diltiazem on ET-l-induced heart disorders appear to be due to their direct actions on coronary vascular smooth muscle and the myocardium.
摘要
  1. 在麻醉大鼠中研究了新型血管扩张剂KRN2391对内皮素-1(ET-1)引起的心电图变化的影响,并与尼可地尔和地尔硫䓬的作用进行了比较。此外,还研究了KRN2391对豚鼠乳头肌动作电位的影响。2. 冠状动脉内注射(i.c.)ET-1(5微克)不仅会因冠状动脉收缩导致心电图ST段抬高,还会引发包括房室传导阻滞(A-V阻滞)、室性早搏(VPC)和室颤(VF)在内的心律失常,并导致大多数动物死亡。然而,注射乙酰甲胆碱(3微克,i.c.)仅产生ST段抬高,未出现心律失常。3. 静脉注射KRN2391(30微克/千克)预处理可抑制ET-1引起的ST段抬高和心律失常的发生,并降低死亡率。4. 尼可地尔(1000微克/千克)可预防ST段抬高,但不抑制VF的发生。地尔硫䓬(100微克/千克)可抑制ST段抬高和VF的发生,但对其他心律失常无效。3000微克/千克的尼可地尔和300微克/千克的地尔硫䓬不仅可抑制ST段抬高和VF发生率,还可减少心律失常的发生。这些剂量的尼可地尔和地尔硫䓬可剂量依赖性地降低死亡率。5. KRN2391(10和30微克/千克)、尼可地尔(1000和3000微克/千克)和地尔硫䓬(100和300微克/千克)可剂量依赖性地显著降低平均血压。尼可地尔(3000微克/千克)和地尔硫䓬(100和300微克/千克)可降低心率,但KRN2391(10和30微克/千克)对心率无影响。6. KRN2391(30微摩尔)可显著缩短豚鼠心室在复极化50%和90%时的动作电位时程(APD50和APD90)。K+通道阻滞剂格列本脲(30微摩尔)可抑制KRN2391的作用。7. 这些结果表明,ET-1引起的ST段抬高和心律失常的发生是由于其对冠状动脉血管平滑肌和心肌的双重直接作用。因此,KRN2391、尼可地尔和地尔硫䓬对ET-1诱导的心脏疾病的保护作用似乎是由于它们对冠状动脉血管平滑肌和心肌的直接作用。

相似文献

本文引用的文献

8
Molecular mechanism of action of the vasoconstrictor peptide endothelin.血管收缩肽内皮素的分子作用机制。
Biochem Biophys Res Commun. 1988 Dec 30;157(3):977-85. doi: 10.1016/s0006-291x(88)80970-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验